AWM
MIST icon

AE Wealth Management’s Milestone Pharmaceuticals MIST Stock Holding History

AE Wealth Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Buy
+15,000
New +$26.3K ﹤0.01% 2173

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

AE Wealth Management's MIST Position: Q1 2026 in Review

AE Wealth Management opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 15,000 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #2173 among its holdings.

86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • AE Wealth Management held 15,000 shares of Milestone Pharmaceuticals worth $17.9K as of Q1 2026.
  • Milestone Pharmaceuticals was a new AE Wealth Management position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of AE Wealth Management's portfolio in Q1 2026, its #2173 holding.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.